FDA cautions against off-label use of Pfizer/BioNTech Covid-19 vaccine in younger children
CNN
Even though the US Food and Drug Administration has fully approved the Pfizer/BioNTech Covid-19 vaccine for people age 16 and older, and it remains authorized for people as young as 12, the agency is warning against using the vaccine "off-label" in children younger than 12. To do so, it says, "would not be appropriate."
Off-label refers to an approved product being used in a way or in a patient that it wasn't necessarily approved for; it happens commonly with some drugs, such as when a chemotherapy approved for one type of cancer is used to treat a different type.More Related News
Tulsi Gabbard, Donald Trump’s pick to lead the intelligence community, was briefly placed on a Transportation Security Administration list that prompts additional security screening before flights after her overseas travel patterns and foreign connections triggered a government algorithm earlier this year, three sources familiar with the matter told CNN.